Literature DB >> 10411820

The effects of first-trimester diabetes control on the incidence of macrosomia.

E Rey1, C Attié, A Bonin.   

Abstract

OBJECTIVE: The aim of this study was to explore the association between glycosylated hemoglobin concentrations during pregnancy and macrosomia. STUDY
DESIGN: One hundred thirty-six pregnancies in 120 women with type 1 or type 2 diabetes were studied longitudinally between January 1, 1991, and December 31, 1996. Glycosylated hemoglobin concentration and several maternal variables of mothers of neonates who were large for gestational age were compared with those of neonates who were appropriate for gestational age. Receiver-operator characteristic curves and regression analyses were used to determine a threshold related to macrosomia and to assess its predictive value.
RESULTS: Glycosylated hemoglobin concentrations throughout pregnancy were higher in mothers of neonates who were large for gestational age (n = 65) than in mothers of neonates who were appropriate for gestational age (n = 71, P <. 001). A first-trimester glycosylated hemoglobin concentration of >/=5.5% (3 SD above the normal mean) was established by receiver-operator characteristic curves as the strongest predictor of macrosomia and yielded an odds ratio of 24 in multiple logistic regression analysis.
CONCLUSION: Macrosomia is determined mainly by first-trimester diabetes control.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411820     DOI: 10.1016/s0002-9378(99)70460-6

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  12 in total

Review 1.  Glycemic targets in pregnancies affected by diabetes: historical perspective and future directions.

Authors:  Teri L Hernandez
Journal:  Curr Diab Rep       Date:  2015-01       Impact factor: 4.810

2.  Biochemical profile and outcome in normal and high risk subjects.

Authors:  K G Vijayalaxmi; Asna Urooj
Journal:  Indian J Clin Biochem       Date:  2009-09-16

3.  Outcome of pregnancy in type 1 diabetes mellitus (T1DMP): results from combined diabetes-obstetrical clinics in Dublin in three university teaching hospitals (1995-2006).

Authors:  R Al-Agha; R G Firth; M Byrne; S Murray; S Daly; M Foley; S C Smith; B T Kinsley
Journal:  Ir J Med Sci       Date:  2011-11-05       Impact factor: 1.568

4.  Brief hyperglycaemia in the early pregnant rat increases fetal weight at term by stimulating placental growth and affecting placental nutrient transport.

Authors:  Anette Ericsson; Karin Säljö; Eleonor Sjöstrand; Nina Jansson; Puttur D Prasad; Theresa L Powell; Thomas Jansson
Journal:  J Physiol       Date:  2007-04-12       Impact factor: 5.182

5.  Sibling birthweight as a predictor of macrosomia in women with type 1 diabetes.

Authors:  A Kerssen; H W de Valk; G H A Visser
Journal:  Diabetologia       Date:  2005-07-14       Impact factor: 10.122

6.  ATLANTIC DIP: closing the loop: a change in clinical practice can improve outcomes for women with pregestational diabetes.

Authors:  Lisa A Owens; Gloria Avalos; Breda Kirwan; Louise Carmody; Fidelma Dunne
Journal:  Diabetes Care       Date:  2012-08       Impact factor: 19.112

7.  Fetal overgrowth in women with type 1 and type 2 diabetes mellitus.

Authors:  Linnea Ladfors; Nael Shaat; Nana Wiberg; Anastasia Katasarou; Kerstin Berntorp; Karl Kristensen
Journal:  PLoS One       Date:  2017-11-09       Impact factor: 3.240

8.  Gestational diabetes mellitus diagnosed at 24 to 28 weeks of gestation in older and obese Women: Is it too late?

Authors:  Wonjin Kim; Soo Kyung Park; Yoo Lee Kim
Journal:  PLoS One       Date:  2019-12-16       Impact factor: 3.240

Review 9.  The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy.

Authors:  Gernot Desoye; Christopher J Nolan
Journal:  Diabetologia       Date:  2016-03-19       Impact factor: 10.122

Review 10.  Biomarkers for Macrosomia Prediction in Pregnancies Affected by Diabetes.

Authors:  Sofia Nahavandi; Jas-Mine Seah; Alexis Shub; Christine Houlihan; Elif I Ekinci
Journal:  Front Endocrinol (Lausanne)       Date:  2018-07-31       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.